UCLA cardiologists use new methods to treat life-threatening arrhythmias

June 8, 2010

(PhysOrg.com) -- Ventricular arrhythmias — abnormal rhythms from the lower chambers of the heart — are typically treated using a combination of medication, implanted defibrillators and catheter ablation. However, for a small subset of patients, such as those who experience a ventricular electrical storm (three or more episodes within a 24-hour period), such arrhythmias pose serious medical emergencies and require further treatment.

In a study of 14 patients with , cardiologists at the UCLA Center used two newer therapies to control these life-threatening arrhythmias and found that the methods may effectively reduce signals from the central nervous system to the heart, which can control or stop the arrhythmias.

The researchers used thoracic epidural anesthesia, which is applied with a small catheter between discs in the upper and can be used as a bridge to or cardiac transplant, and left cardiac sympathetic denervation, an additional treatment for select patients that involves endoscopic interruption of the nerves that come out of the spinal cord and give rise to fibers that reach the heart.

The UCLA cardiologists found that the procedures were well tolerated and may provide a new approach in arrhythmia treatment by helping modulate the .

Thoracic epidural anesthesia and left cardiac sympathetic denervation may help control or stop ventricular arrhythmias when further treatment is needed. Ventricular arrhythmias are thought to be responsible for 250,000 deaths a year in the United States.

Researchers say the next step is further evaluation in randomized clinical trials. A large study is currently being led by the team at UCLA, in collaboration with researchers at the Mayo Clinic and centers in Italy and India.

The research appears in the June 1 edition of Circulation, the journal of the American Heart Association.

Related Stories

Recommended for you

Artificial beta cells

December 8, 2016

Researchers led by ETH Professor Martin Fussenegger at the Department of Biosystems Science and Engineering (D-BSSE) in Basel have produced artificial beta cells using a straightforward engineering approach.

Key regulator of bone development identified

December 8, 2016

Loss of a key protein leads to defects in skeletal development including reduced bone density and a shortening of the fingers and toes—a condition known as brachydactyly. The discovery was made by researchers at Penn State ...

Researchers question lifelong immunity to toxoplasmosis

December 8, 2016

Medical students are taught that once infected with Toxoplasma gondii—the "cat parasite"—then you're protected from reinfection for the rest of your life. This dogma should be questioned, argue researchers in an Opinion ...

0 comments

Please sign in to add a comment. Registration is free, and takes less than a minute. Read more

Click here to reset your password.
Sign in to get notified via email when new comments are made.